66. IgA腎症 IgA nephropathy Clinical trials / Disease details

臨床試験数 : 275 / 薬物数 : 258 - (DrugBank : 82) / 標的遺伝子数 : 36 - 標的パスウェイ数 : 140

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05383547 (ClinicalTrials.gov)	August 2, 2022	10/5/2022	Bortezomib for Treating Glomerular Diseases	Prospective Observation of Bortezomib in the Treatment of Glomerular Diseases	Bortezomib;Glomerulonephritis;MN;MPGN;FSGS;IgA Nephropathy	Drug: Bortezomib	Ruijin Hospital	NULL	Recruiting	18 Years	65 Years	All	20	N/A	China
2	NCT01103778 (ClinicalTrials.gov)	July 2010	13/4/2010	Pilot Study of Velcade® in IgA Nephropathy	Velcade Therapy for Severe IgA Nephropathy	Chronic Kidney Disease;IgA Nephropathy	Drug: Bortezomib (Velcade®)	The Rogosin Institute	Weill Medical College of Cornell University	Completed	18 Years	N/A	All	11	Phase 4	United States

First Previous1Next Last